Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
Amgen
Description:
An American multinational biotechnology company that develops and markets biopharmaceutical medicines.
Related topics:
Pharmaceutical Economics and Policy (18%),
Architecture, Modernity, and Design (10%)
Wikidata ID:
wiki/Q470517
OpenAlex ID:
keywords/amgen
Why Did NASDAQ Market Makers Stop Avoiding Odd‐Eighth Quotes?
1994
·
WILLIAM G. CHRISTIE
, JEFFREY H. HARRIS
, et al.
·
The Journal of Finance
·
369
Amgen All Over, Sagging Suplier Sector
1990
·
C Zhou
, Y Yang
, et al.
·
Nature Biotechnology
·
269
Bispecific antibodies rise again
2014
·
Ken Garber
·
Nature Reviews Drug Discovery
·
132
Romosozumab: First Global Approval
2019
·
Anthony Markham
·
Drugs
·
96
Erenumab: First Global Approval
2018
·
Anthony Markham
·
Drugs
·
83
The golden helix: inside biotech ventures
1996
·
Choice Reviews Online
·
62
The Long and the Short of Bone Therapy
2006
·
Michael P. Whyte
·
New England Journal of Medicine
·
58
Biotech giant publishes failures to confirm high-profile science
2016
·
Monya Baker
·
Nature
·
53
PDF
Suicidal thoughts end Amgen's blockbuster aspirations for psoriasis drug
2015
·
Charlie Schmidt
·
Nature Biotechnology
·
41
Amgen's bispecific antibody puffs across finish line
2015
·
Cormac Sheridan
·
Nature Biotechnology
·
41
Science Lessons: What the Business of Biotech Taught Me About Management
2008
·
Gordon Binder
, Philip Bashe
·
39
Last of the Big-Time Spenders?
2003
·
Andrew Lawler
·
Science
·
33
The innovative evolution of cancer gene and cellular therapies
2013
·
P Lam
, G Khan
, et al.
·
Cancer Gene Therapy
·
32
PDF
Amgen spikes interest in live virus vaccines for hard-to-treat cancers
2011
·
Charlie Schmidt
·
Nature Biotechnology
·
29
Humira: the Impending Patent Battles Over Adalimumab Biosimilars
2016
·
Peter Norman
·
Pharmaceutical Patent Analyst
·
28
FDA approves first bispecific
2014
·
Asher Mullard
·
Nature Reviews Drug Discovery
·
26
Amgen announces oncolytic virus shrinks tumors
2013
·
Cormac Sheridan
·
Nature Biotechnology
·
24
Amgen overcomes historically undruggable target, with FDA nod for first KRAS inhibitor
2021
·
Asher Mullard
·
Nature Reviews Drug Discovery
·
20
Cryogen‐free 400‐MHz nuclear magnetic resonance spectrometer as a versatile tool for pharmaceutical process analytical technology
2024
·
Maria Victoria Silva Elipe
, Ikenna Edward Ndukwe
, et al.
·
Magnetic Resonance in Chemistry
·
17
FDA approves thrombopoiesis-stimulating agent
2008
·
Cheryl A. Thompson
·
American Journal of Health-System Pharmacy
·
17
Amgen Decision to Halt Gdnf Clinical Trials and Withdraw the Drug Triggers Protest From Researchers and Patients
2005
·
Peggy Peck
·
Neurology Today
·
17
Recent deal highlights hopes for cancer-killing viruses
2011
·
Jon Evans
·
Nature Medicine
·
15
Darbepoetin alfa. Amgen.
2001
·
F Locatelli
, L D Vecchio
·
PubMed
·
15
Capitalizing on the genome
1996
·
Nature Genetics
·
15
PDF
Oncologists greet Lumakras: the world’s first KRAS inhibitor
2021
·
Cormac Sheridan
·
Nature Biotechnology
·
13
Show more works
View as search
Works count:
722
Citation count:
2,042
Year
Topic
Type